Patent · US Active

Hybrid proteins of active-site serine β-lactamase

US7745193B2 · kind B2 · utility

10Cited by

1References

12Claims

0Family size

Assignee

UNIVERSITE DE LIEGE · BE

Inventors

Fabrizio Giannotta · Waremme, BE
Patrice Filee · Jupille, BE
Moreno Galleni · Liège, BE
Jean-Marie Frere · Amay, BE
Bernard Joris · Spa, BE
Alain Brans · Beaufays, BE
Nadia Ruth · Liège, BE

Key dates

Filing date	Jan 17, 2005
Grant date	Jun 29, 2010
Priority date	—
Expiry date	Jun 23, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention refers to a recombinant nucleotide sequence which codes upon expression for at least a part of a bifunctional hybrid active-site serine β-lactamase protein, wherein the β-lactamase protein is bearing at least one heterologous sequence, wherein in that the hybrid protein is having two functions, the first function is associated with the β-lactamase portion and the second function is associated with the heterologous sequence having a biological function which is different from the first function.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.